MALIGNANT NEOPLASM
Clinical trials for MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug MK-4884 enters first human tests for tough cancers
Disease control Not yet recruitingThis early-stage study tests a new drug called MK-4884 in people with advanced or spreading solid tumors (like colorectal, kidney, lung, or bile duct cancer). The main goal is to check the drug's safety and find the right dose. About 120 participants will receive the drug, and re…
Matched conditions: MALIGNANT NEOPLASM
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 06:53 UTC
-
Could existing melanoma drugs work for other rare cancers? new trial aims to find out.
Disease control Not yet recruitingThis trial tests whether two drugs already approved for certain skin and lung cancers can help people with rare cancers that have a specific gene change called BRAF V600. About 30 adults and children with various rare cancers will receive dabrafenib and trametinib. The goal is to…
Matched conditions: MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control
Last updated May 26, 2026 06:45 UTC
-
Can a simple breath ease cancer nausea? new trial investigates
Symptom relief Not yet recruitingThis study tests whether inhaling isopropyl alcohol can reduce nausea in cancer patients. About 112 participants who rate their nausea as moderate to severe will be randomly assigned to inhale isopropyl alcohol or a placebo. The goal is to see if this simple, drug-free approach p…
Matched conditions: MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated May 18, 2026 12:01 UTC